SELECTBIO Conferences Point-of-Care Diagnostics & Global Health 2018
Point-of-Care Diagnostics & Global Health 2018
Date: October 1 - 3, 2018
Venue: Coronado Island, San Diego, California, USA

Keynote Speakers

John McDevitt

John McDevitt
Chair, Department Biomaterials, New York University College of Dentistry Bioengineering Institute

Dino Di Carlo

Dino Di Carlo
Professor and Vice Chair of Bioengineering, University of California-Los Angeles

Hsueh-Chia Chang

Hsueh-Chia Chang
Bayer Professor of Engineering, University of Notre Dame

Chwee Teck Lim

Chwee Teck Lim
Provost's Chair Professor, Principal Investigator, Mechanobiology Institute, Department of Biomedical Engineering, National University of Singapore

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas

Martyn Boutelle

Martyn Boutelle
Professor of Biomedical Sensors Engineering, Vice Chair Department of Bioengineering, Imperial College London

Michael Heller

Michael Heller
Distinguished Scientist - Knight Cancer Institute at Oregon Health & Science University (OHSU), Center for Cancer Early Detection and Research (CEDAR); Professor, University of California-San Diego

John Brennan

John Brennan
Professor and Director, Biointerfaces Institute, McMaster University

Arben Merkoci

Arben Merkoci
ICREA Research Professor and Group Leader, Catalan Institute of Nanoscience and Nanotechnology Barcelona

Bernhard Weigl

Bernhard Weigl
Principal Investigator, Flow Based Diagnostics, Intellectual Ventures/Global Good, University of Washington

Overview

Welcome to the Select Biosciences Point-of-Care Diagnostics and Global Health 2018.

This annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and bring in the Emerging Viral Diseases field providing the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval.  Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.

This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents approximately 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.

Registered conference delegates have full access to the co-located parallel conferences:
  • Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2018
  • Lab-on-a-Chip and Microfluidics: Techologies and Commercialization 2018
  • Point-of-Care Diagnostics and Global Health 2018
  • Biodetection and Biosensors Summit 2018
  • Single Cell Analysis Summit 2018

Call for Posters

You can also present your research on a poster while attending the meeting.

Poster Submission Deadline: 24 September 2018

Agenda Topics

  • Emerging Technologies and Emerging Companies Showcase
  • Global Health and Emerging Viral Diseases such as Ebola and Zika
  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
    • Innovations in Technology Development
  • POC Diagnostics for Global Health: A Worldwide Perspective
    • Low-Cost POC Devices for Deployment Worldwide
    • POC Diagnostics in Resource-Limited Settings
  • POC Diagnostics in Infectious Disease Testing

Sponsorship and Exhibition Opportunities

For more details, please contact us.

Confirmed Speakers to date

Amy Adelberger, Founder and CEO, Global Impact Advisors
Jane Brock, Chief of Breast Pathology, Brigham and Women’s Hospital
Charles Daitch, CEO, Akonni Biosystems Inc.
Jim Gallarda, Senior Program Officer, Bill & Melinda Gates Foundation
Robert Meagher, Principal Member of the Technical Staff, Sandia National Laboratories
Claudio Parolo, Research Fellow, University of California-Santa Barbara
Alexandra Perebikovsky, Researcher, University of California-Irvine
Chaminda Salgado, Cell & Gene Therapy Medicinal Process Delivery Leader, GlaxoSmithKline
Paul Yager, Professor, Department of Bioengineering, University of Washington


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Japanese
Traditional Chinese
Simplified Chinese
Korean